AlphaTON Capital skyrockets on blockchain-based cancer drug funding plans

Alpha Compute

08/10/2025 18:23

** Shares of digital asset treasury company AlphaTON Capital Corp ATON.O surge 95.69% to $10.92

** Earlier in session, co's shares hit over 5-month high of $13.80

** Co and its oncology unit Tarus Therapeutics are exploring ways to fund the development of cancer treatments using digital assets

** ATON signs non-binding letter of intent (LOI) to look into tokenizing the financial value of TT-4, a cancer drug being developed to treat mesothelioma

** Unit says first-patient dosing with TT-4 is targeted for Q1 2026

** YTD, the stock has risen ~107%, including session's moves

 (Reporting by Krisha Bhatt)

 ((Krisha.Bhatt@thomsonreuters.com;))